Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 85-95

  Qin, Yao ^a,b   Chen, Huali ^a   Yuan, Wenmin ^a   Kuai, Rui ^a   Zhang, Qianyu ^a   Xie, Fulan ^a   Zhang, Li ^a   Zhang, Zhirong ^a   Liu, Ji ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

^b Taiji Group   (China)

Author keywords

Blood brain barrier; Brain delivery; Cholesterol; Liposome; TAT

Indexed keywords

CHOLESTEROL; LIPOSOME; TRANSACTIVATING TRANSDUCTION MODIFIED LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CELL METABOLISM; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CHOLESTEROL; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; GENE PRODUCTS, TAT; LIPOSOMES; MALE; MICE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 80053563934     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.021     Document Type: Article

References (43)

1. W.A. Banks, S.M. Robinson, and A. Nath Permeability of the blood-brain barrier to HIV-1 Tat Exp. Neurol. 193 2005 218 227 (Pubitemid 40463283)
2. H. Brooks, B. Lebleu, and E. Vives Tat peptide-mediated cellular delivery: back to basics Adv. Drug Deliv. Rev. 57 2005 559
3. F.L. Cardoso, D. Brites, and M.A. Brito Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches Brain Res. Rev. 64 2010 328 363
4. R. Cecchell, V. Berezowski, S. Lundquis, M. Culot, M. Renfte, M.P. Dehouck, and L. Fenart Modelling of the blood-brain barrier in drug discovery and development Nat. Rev. Drug Discov. 6 2007 650 661 (Pubitemid 47202487)
5. Y. Chen, G. Dalwadi, and H.A.E. Benson Drug delivery across the blood-brain barrier Cur. Drug Deliv. 1 2004 361 376
6. Q. Chen, T. Gong, J. Liu, X. Wang, H. Fu, Y. Li, and Zhang S Z. Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery J. Drug Target. 4 2009 318 328
7. H. Chen, L. Tang, Y. Qin, Y. Yin, J. Tang, W. Tang, X. Sun, Z. Zhang, J. Liu, and Q. He Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery Eur. J. Pharm. Sci. 40 2010 94 102
8. B. Chertok, A.E. David, B.A. Moffat, and V.C. Yang Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking Biomaterials 30 2009 6780 6787
9. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor independent J. Biol. Chem. 271 1996 18188 18193 (Pubitemid 26250811)
10. J. Du, W.-L. Lu, X. Ying, Y. Liu, P. Du, W. Tian, Y. Men, J. Guo, Y. Zhang, R.-J. Li, J. Zhou, J.-N. Lou, J.-C. Wang, X. Zhang, and Q. Zhang Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals Mol. Pharm. 6 2008 905 917
11. S. Fawell Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U.S.A. 91 1994 664 668 (Pubitemid 24041462)
12. J.V. Frangioni In vivo near-infrared fluorescence imaging Curr. Opin. Chem. Biol. 7 2003 626 634 (Pubitemid 37315800)
13. H.D. Han, A. Lee, C.K. Song, T. Hwang, H. Seong, C.O. Lee, and B.C. Shin In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes Int. J. Pharm. 313 2006 181 188
14. K. Hu, J. Li, Y. Shen, W. Lu, X. Gao, Q. Zhang, and X. Jiang Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations J. Control. Release 134 2009 55 61
15. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
16. A. Kheirolomoom, and K.W. Ferrara Cholesterol transport from liposomal delivery vehicles Biomaterials 28 2007 4311 4320 (Pubitemid 47212402)
17. D.D. Lasic Doxorubicin in sterically stabilized liposomes Nature 380 1996 561 562
18. S.-D. Li, and L. Huang Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Control. Release 145 2010 178 181
19. L. Liu, K. Guo, J. Lu, S.S. Venkatraman, D. Luo, K.C. Ng, E.-A. Ling, S. Moochhala, and Y.-Y. Yang Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier Biomaterials 29 2008 1509 1517
20. E.P. Loret, E. Vives, P.S. Ho, H. Rochat, J. Van Rietschoten, and W.C. Johnson Jr. Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization Biochemistry 30 1991 6013 6023
21. W. Lu, Y.-Z. Tan, K.-L. Hua, and X.-G. Jiang Cationic albumin conjugated PEGylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier Int. J. Pharm. 295 2005 247 260 (Pubitemid 40558807)
22. C.R. Miller, B. Bondurant, S.D. Mc Lean, K.A. Mc Govern, and D.F. O'Brien Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes Biochemistry 37 1998 12875 12883 (Pubitemid 28433520)
23. H.B. Newton Advances in strategies to improve drug delivery to brain tumors Expert Rev. Ther. 6 2006 1495 1509 (Pubitemid 44690919)
24. V. Ntziachristos, C. Bremer, and R. Weissleder Fluorescence imaging with near infrared light: new technological advances that enable in vivo molecular imaging Eur. Radiol. 13 2003 195 208 (Pubitemid 36790510)
25. P.A. Orlandi, and P.H. Fishman Filipin-dependent inhibition of cholera toxin evidence for toxin internalization and activation through caveolae-like domains J. Cell Biol. 141 1998 905 915 (Pubitemid 28243959)
26. W.M. Pardridge New approaches to drug delivery through the blood-brain barrier Trends Biotechnol. 12 1994 239 245 (Pubitemid 24190552)
27. W.M. Pardridge Why is the global CNS pharmaceutical market so under-penetrated? Drug Discov. Today 7 2002 5 7 (Pubitemid 34093938)
28. M.J. Parr, S.M. Ansell, L.S. Choi, and P.R. Cullis Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles Biochim. Biophys. Acta 1195 1994 21 30 (Pubitemid 24318087)
29. W. Pham, B.-Q. Zhao, E.H. Lo, Z. Medarova, B. Rosen, and A. Moore Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging Neuroimage 28 2005 287 292 (Pubitemid 41393908)
30. Y. Qin, W. Fan, H. Chen, N. Yao, W. Tang, J. Tang, W. Yuan, R. Kuai, Z. Zhang, Y. Wu, and Q. He In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes J. Drug Target. 18 2010 536 549
31. S. Santra, H. Yang, J.T. Stanley, P.H. Holloway, B.M. Moudgil, and G. Walter Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots Chem. Commun. 25 2005 3144 3146 (Pubitemid 41002376)
32. J.E. Schnitzer, P. Oh, E. Pinney, and J. Allard Filipin-sensitive caveolae mediated transport in endothelium reduced transcytosis, scavenger endocytosis and capillary permeability of select macromolecule J. Cell Biol. 127 1994 1217 1232 (Pubitemid 24362558)
33. S.R. Schwarze In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572 (Pubitemid 29420581)
34. A. Siflinger-Birnboim, P.J. Del Becchio, J.A. Cooper, F.A. Blumenstock, J.N. Shepard, and A.B. Malik Molecular sieving characteristics of the cultured endothelial monolayer J. Cell. Physiol. 132 1987 111 117 (Pubitemid 17105330)
35. J. Temsamani, and J.M. Scherrmann Peptide vectors as drug carriers Prog. Drug Res. 61 2003 221 238 (Pubitemid 37187408)
36. J. Temsamani, and P. Vidal The use of cell-penetrating peptides for drug delivery Drug Discov. Today 9 2004 1012 1019 (Pubitemid 39574557)
37. B.J. Tromberg, B.W. Pogue, K.D. Paulsen, A.G. Yodh, D.A. Boas, and A.E. Cerussi Assessing the future of diffuse optical imaging technologies for breast cancer management Med. Phys. 35 2008 2443 2451 (Pubitemid 351748652)
38. E. Vivs, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017 (Pubitemid 27265584)
39. J.S. Wadia, and S.F. Dowdy Protein transduction technology Curr. Opin. Biotechnol. 13 2002 52 56 (Pubitemid 34146548)
40. M. William, and T. Pardridge Drug and gene targeting to the brain via blood-brain barrier receptor-mediated transport systems Int. Congr. Ser. 1277 2005 49 62
41. R.X. Xu, D.C. Young, J.J. Mao, and S.P. Povoski A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions Breast Cancer Res. 9 2007 R88
42. M. Zhao, and R. Weissleder Intracellular cargo delivery using Tat peptide and derivatives Med. Res. Rev. 24 2004 1 12 (Pubitemid 38018593)
43. X.B. Zhao, N. Muthusamy, J.C. Byrd, and R.J. Lee Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes J. Pharm. Sci. 96 2007 2424 2439